R-Oprah

History

2023: Launch of a plant for the production of anticancer drugs for 7 billion rubles

On August 21, 2023, the official launch of the R-Opra pharmaceutical plant took place on the territory of the special economic zone (SEZ) Technopolice Moscow"" in Zelenograd. This event was attended by the Deputy Prime Minister Minister of Industry and Trade Denis Manturov and the Mayor. Moscow Sergei Sobyanin

The company will also produce vital and modern drugs for the treatment of:

• oncological and orphan diseases,
• respiratory diseases,
• rheumatic and cardiovascular diseases,
• neurological disorders,
• nephrological diseases,
• HIV infections.

The official launch of the pharmaceutical plant "R-Opra" in Zelenograd took place

The preparations will be produced in solid dosage forms, in the form of sterile solutions and lyophilisates, as well as in soft gelatin capsules and powders for inhalation in capsules.

The production was created as part of an offset contract with the Moscow government, the investments of the R-Pharm group amounted to 6.99 billion rubles.

We are launching production at our first offset plant in Moscow. Basically, this is an import-substituting portfolio of drugs. I would like to confirm R-Pharm's commitment to offsets as a mechanism for implementing projects for the production of Russian medicines. We took advantage of a wide range of support measures, both from the Moscow Government and from the Ministry of Industry and Trade. This is a subsidized loan rate, and the FRP took part. And, of course, the offset itself is the spine, the spine of the entire project, "said Vasily Ignatiev, General Director of R-Pharm.

The offset contract for the creation of a new pharmaceutical enterprise was concluded in 2018. In accordance with it, the R-Pharm group of companies has undertaken to build a full-cycle production complex in Alabushev with an area of ​ ​ more than 30.5 thousand square meters. The plant will produce 26 international generic names of drugs for the therapy of cancer, autoimmune, asthmatic and other diseases. In turn, the Moscow Government guaranteed the purchase of manufactured drugs for seven years.^[1]

2022: Raising 2 billion rubles for the construction of a plant for the production of drugs for cancer and heart disease

On January 24, 2022, the Industrial Development Fund () FRP announced the provision of R-Oprah (part of the "" group) R-Pharm a preferential loan rubles in the amount of 2 billion for the construction of a pharmaceutical enterprise in. To Moscow This facility will produce drugs for the treatment of cancer, respiratory, anti-rheumatic, neurological, nephrological, cardiovascular, orphan diseases, HIV infections, as well as immunosuppressants.

These drugs, as noted in the R-Opra company, are not produced and supplied from abroad in Russia by the end of January 2022. Drugs will be produced in the form of tablets, capsules, solutions for inhalation, dosage forms for parenteral use in the form of solutions and lyophilisates.

Subsidiary R-Pharm raised 2 billion rubles for the construction of a plant for the production of drugs for cancer and heart disease

The new production will be located in the SEZ "Technopolice Moscow" at the site "Alabushevo" in Moscow Zelenograd. The company plans to create about 300 workplaces. The total project budget is estimated at 7.4 billion rubles.

The creation in Moscow of a modern high-tech pharmaceutical production that provides Russian patients with access to innovative drugs is the most important task, for the implementation of which it is necessary to spend a significant amount of money, "said Olga Molotkova, project manager at R-Oprah.

By the end of January 2022, the construction of the enterprise in the SEZ Technopolice Moscow is nearing completion, the launch of the first stage of production is scheduled for 2022, and the commissioning of the site at full capacity in 2023, R-Opra reported.

R-Oprah was the only participant in the tender for the conclusion of an offset contract, offering to fulfill it for 18.4 billion rubles. R-Oprah pledged to invest 5.87 billion rubles in organizing in Moscow the production of drugs for the therapy of oncological, cardiological, psychiatric diseases, and the Moscow authorities to purchase them from R-Oprah in 2022-2028^[2]

Notes